Novo Nordisk (NYSE: NVO) and Regeneron Pharmaceuticals (NASDAQ: REGN), two leading drugmakers, have underperformed for most ...

Beneath the surface of this attention lies a complex reality for many tall Nigerians, encompassing struggles with fashion ...

Elon Musk sees "rough quarters." A likely "robotaxi" launch in San Francisco comes with caveats. BYD is near a buy point.